AB
AEON BiopharmaClinical-stage biopharmaceutical company developing ABP-450 (prabotulinumtoxinA), a biosimilar to Botox, for therapeutic indications like cervical dystonia and chronic migraine.
1 Pulse story
EM
Encore MedicalEncore Medical develops transcatheter septal occlusion devices to repair structural heart defects like patent foramen ovale (PFO).
2 Pulse stories
Total RaisedNot disclosed
Last ValuationNot disclosed
Biotech
Sector
Biotech
2013
Founded
2017
Irvine, California
HQ
Eagan, Minnesota
Public (AEON)
Status
Public (EMI)
AEON Biopharma investors
No investors on record.
Encore Medical investors
No investors on record.
Data from Value Add Pulse coverage and company research — see the full threads for AEON Biopharma and Encore Medical.